INT259881

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.35
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.16
Pain Relevance 0.27

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (LTB4R) signal transducer activity (LTB4R)
LTB4R (Homo sapiens)
Pain Link Frequency Relevance Heat
antagonist 14 89.84 High High
Bioavailability 1 88.88 High High
Inflammation 12 58.08 Quite High
agonist 14 5.00 Very Low Very Low Very Low
Bile 2 5.00 Very Low Very Low Very Low
palliative 1 5.00 Very Low Very Low Very Low
COX2 1 5.00 Very Low Very Low Very Low
cytokine 1 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
chemokine 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
INFLAMMATION 11 58.08 Quite High
Cancer 43 54.08 Quite High
Asthma 2 50.12 Quite High
Hypersensitivity 1 39.56 Quite Low
Anaphylactic Hypersensitivity 1 39.16 Quite Low
Infection 2 36.16 Quite Low
Ulcers 1 22.08 Low Low
Atrophic Gastritis 1 19.92 Low Low
Cleidocranial Dysplasia 1 16.88 Low Low
Adenocarcinoma 5 15.76 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
two compounds from the Lilly Research Laboratories potently block LTB4 binding to its receptors within the nM range and inhibit the biological
Negative_regulation (block) of LTB4 Binding (binding) of
1) Confidence 0.35 Published 2008 Journal PPAR Research Section Body Doc Link PMC2631651 Disease Relevance 0.16 Pain Relevance 0.27

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox